| 1 Jan–31 Dec | 1 Jan–31 Dec | ||
| EUR thousand Notes | 2024 | 2023 | |
| Other comprehensive income | |||
| Items which may be reclassified | |||
| subsequently to profit or loss | |||
Translation difference | - | - | |
Total comprehensive income | |||
| Distribution of comprehensive income: | |||
Parent company shareholders |
| 1 Jan–31 Dec | 1 Jan–31 Dec | ||
EUR thousand | Notes | 2024 | 2023 |
Net sales | 2 | ||
Other operating income | 3 | ||
Materials and services | 4 | - | - |
Personnel expenses | 5, 18, 22 | - | - |
Depreciation, amortization and impairment | 7 | - | - |
Other operating expenses | 8 | - | - |
Operating result | |||
Financial income | 9 | ||
Financial expenses | 9 | - | - |
Earnings before tax | |||
Income taxes | 10 | - | - |
Net profit | |||
| Distribution of net profit: | |||
Parent company shareholders | |||
| Net profit attributable to parent company | |||
| shareholders, earnings per share | |||
Undiluted earnings per share (EUR/share) | 11 | ||
Diluted earnings per share (EUR/share) | 11 |
EUR thousand | Notes | 31 Dec 2024 | 31 Dec 2023 |
| Non-current assets | |||
Goodwill | 12 | ||
Other intangible assets | 12 | ||
Tangible assets | 13 | ||
Long-term receivables | |||
Contract assets | 2 | ||
Deferred tax assets | 14 | ||
Total non-current assets | |||
| Current assets | |||
Trade receivables | 15 | ||
Other receivables | 15 | ||
Contract assets | 2 | ||
Cash and cash equivalents | 16 | ||
Total current assets | |||
Total assets |
EUR thousand | Notes | 31 Dec 2024 | 31 Dec 2023 |
| Shareholders’ equity | |||
Share capital | 17 | ||
Unrestricted shareholders’ equity reserve | 17 | ||
Own shares | 17 | - | - |
Translation difference | 17 | ||
Retained earnings | 17, 18 | ||
Net profit | |||
Total shareholders’ equity | |||
| Long-term liabilities | |||
Deferred tax liabilities | 14 | ||
Long-term interest-bearing liabilities | 20 | ||
Other long-term liabilities | 19 | ||
Total long-term liabilities | |||
| Short-term liabilities | |||
Short-term interest-bearing liabilities | 19, 20 | ||
Accounts payable | 19 | ||
Other short-term liabilities | 19 | ||
Total short-term liabilities | |||
Total liabilities |
| 1 Jan–31 Dec | 1 Jan–31 Dec | ||
| 2024 | 2023 | EUR thousand | |
| Profit before taxes | |||
| Adjustments to net profit | |||
| Depreciation and amortization | |||
| Other adjustments | - | ||
| Change in working capital | |||
| Change in trade and other receivables | - | - | |
| Change in accounts payable and other liabilities | |||
| Interest paid | - | - | |
| Other financial items | |||
| Taxes paid | - | - | |
| Cash flow from operations |
| 1 Jan–31 Dec | 1 Jan–31 Dec | |
| 2024 | 2023 | |
| Purchases of tangible and intangible assets | - | - |
Payment for acquisition of subsidiary, net of cash acquired* | - | - |
| Cash flow from investments | - | - |
| Change in lease liabilities | - | - |
| Share subscriptions based on stock options 2016 | ||
| Repayment of short-term borrowings | - | |
| Repayment of long-term borrowings | - | |
| Cash flow from financing | - | - |
| Change in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of period | ||
| Net foreign exchange difference | - | |
| Cash and cash equivalents at end of period |
| Unrestricted | Total | |||||
| shareholders’ | Translation | Retained | shareholders’ | |||
equity reserve | Own shares | difference | earnings | equity | ||
Shareholders’ equity 1 January 2023 | - | |||||
| Comprehensive income for the period | ||||||
Net profit | ||||||
Comprehensive income | - | - | ||||
Stock option program and equity incentive program | ||||||
| Issue of shares as consideration | ||||||
for a business acquisition | ||||||
Issue of treasury shares | ||||||
Shareholders’ equity 31 December 2023 | - | |||||
Shareholders’ equity 1 January 2024 | - | |||||
| Comprehensive income for the period | ||||||
Net profit | ||||||
Comprehensive income | - | - | ||||
Stock option program and equity incentive program | - | - | ||||
| Issue of shares as consideration | ||||||
for a business acquisition | ||||||
Issue of treasury shares | ||||||
Shareholders’ equity 31 December 2024 | - |
Cash consideration | 26,921 |
Directed share issue | 8,273 |
Earn-out | 9,984 |
Total purchase price consideration | 45,178 |
Total assets | 40,021 |
Short-term liabilities | 3,542 |
Deferred tax liability | 10,260 |
Total liabilities | 13,802 |
Net assets | 26,219 |
Goodwill | 18,959 |
Purchase price | 45,178 |
| Notes to the Consolidated Financial Statements | ||
| Notes to the Consolidated Financial Statements | ||
| Notes to the Consolidated Financial Statements | ||
EUR thousand | 2024 | 2023 |
Personnel expenses | 2,851 | 3,163 |
Travel and representation expenses | 5,000 | 4,400 |
Marketing and communications | 4,269 | 3,733 |
External services | 8,567 | 7,595 |
Costs of premises | 3,303 | 3,193 |
IT expenses | 6,876 | 6,430 |
Other expenses | 1,649 | 1,761 |
Total | 32,515 | 30,277 |
| Notes to the Consolidated Financial Statements | ||
EUR thousand | 2024 | 2023 |
Taxes for the period | 15,333 | 12,182 |
Taxes for previous periods | -62 | -210 |
Other items | - | |
Deferred tax | -2,263 | -2,607 |
Total | 13,132 | 9,365 |
| Reconciliation of tax expenses | ||
| with the tax rate of the Group’s home country (20%) | ||
Earnings before tax | 70,356 | 44,820 |
Taxes calculated at the parent company’s tax rate | 14,071 | 8,964 |
Effect of deviating tax rates of foreign subsidiaries | 27 | 237 |
Income not subject to tax | -1,335 | - |
Share-based payment related expenses | - | |
Non-deductible expenses and other differences | 160 | 403 |
Withholding taxes | - | |
Other items | 271 | -28 |
Taxes for previous periods | -62 | -210 |
Total | 13,132 | 9,365 |
Effective tax rate | 19% | 21% |
| Notes to the Consolidated Financial Statements | ||
| Identified | Total value | |||
| intangible | subject | |||
| EUR thousand | assets | Goodwill | Other items | to testing |
47,068 | 44,370 | 17,981 | 109,419 |
| Right-of-use-assets, | Right-of-use-assets, | Machinery and | ||
| buildings | machinery and equipment | equipment | Total | |
Acquisition cost, 1 January | 7,495 | 2,000 | 3,683 | 13,177 |
Translation differences and other adjustments | - | - | -99 | -99 |
Acquisition of subsidiary | - | - | - | - |
Increases | 2,036 | 423 | 812 | 3,270 |
Disposals | -178 | - | -34 | -212 |
Acquisition cost, 31 December | 9,353 | 2,424 | 4,362 | 16,138 |
Accumulated depreciation and impairment, 1 January | -3,803 | -1,806 | -2,138 | -7,746 |
Translation differences and other adjustments | - | - | 68 | 68 |
Depreciation for the period | -2,058 | -215 | -795 | -3,068 |
Disposals | 108 | - | 26 | 134 |
| Accumulated depreciation | ||||
and impairment, 31 December | -5,753 | -2,021 | -2,840 | -10,614 |
Book value, 1 January | 3,692 | 194 | 1,544 | 5,430 |
Book value, 31 December | 3,600 | 403 | 1,522 | 5,525 |
| Notes to the Consolidated Financial Statements | ||
| Equity incentive program 2022–2024 | |
Grant date | 16 February 2022 |
Nature of the scheme | Shares and cash |
Target group | Key personnel |
Share-based remuneration, maximum number of shares | 130,000 |
Earning period begins, date | 1 January 2022 |
Earning period ends, date | 31 December 2024 |
Vesting conditions | Development of Qt Group Plc’s net sales |
Execution | As shares and cash |
| Effect of option program on the net profit | ||
EUR thousand | 2024 | 2023 |
Equity incentive program 2022–2024 | 1,184 | -376 |
Total | 1,184 | -376 |
| Notes to the Consolidated Financial Statements | ||
| Notes to the Consolidated Financial Statements | ||